Administering a two-drug Tivicay/lamivudine regimen to half of potentially eligible ART-naive HIV-infected individuals could save more than $500 million in treatment costs over 5 years in the ...

The US Food and Drug Administration (FDA) today approved a new drug called dolutegravir (Tivicay, GlaxoSmithKline) as an adjunct to other antiretroviral drugs that treat individuals infected with ...

Please report side effects. See the full CMI for further details. 1. Why am I using TIVICAY PD? TIVICAY PD contains the active ingredient dolutegravir. TIVICAY PD is used to treat HIV (human ...

Back to Healio Regimens that included Tivicay showed significant initial efficacy as salvage therapy in ART-experienced patients with HIV-2 who were resistant to first-generation integrase ...

GlaxoSmithKline plc’s GSK HIV subsidiary, ViiV Healthcare, announced that the FDA has approved the oral suspension of its HIV drug, Tivicay (dolutegravir) tablets, in combination with other ...

WASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Monday it has approved GlaxoSmithKline Plc's drug Tivicay to treat the most common strain of HIV, the virus that causes AIDS.

ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay, a treatment for children living with HIV in Europe - Dolutegravir is the ...